Singular | Jotup

Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference

Retrieved on:

수요일, 5월 29, 2024

SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced plans to present at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, Florida.

Key Points:

SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced plans to present at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, Florida.
Singular Genomics’ management is scheduled to participate in a fireside chat Wednesday, June 12, 2024, at 7:40 a.m. Pacific Time / 10:40 a.m. Eastern Time.
Investors and other interested parties are invited to listen to a live and recorded webcast of the presentation at investor.singulargenomics.com in the Presentations & Events section.

QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision medicine

Retrieved on:

수요일, 5월 29, 2024

The kit offers a streamlined and rapid workflow to generate WGS and WTS libraries from a single sample by combining chemistry optimized for DNA and RNA simultaneously.

Key Points:

The kit offers a streamlined and rapid workflow to generate WGS and WTS libraries from a single sample by combining chemistry optimized for DNA and RNA simultaneously.
Using traditional methods, separate workflows for DNA and RNA sequencing require a large amount of sample material, labor-intensive library preparation procedures, and long turn-around times.
With a focus on front-end sample processing and downstream bioinformatics, QIAGEN provides innovative NGS technologies for genomics, transcriptomics, epigenomics, and metagenomics applications.
QIAGEN’s QIAseq kits have processed over four million NGS samples, enabling biomarker research, gene expression studies, viral epidemiology, and disease surveillance.

Acme United Corporation to Present at the Singular Research Spring Select Webinar on May 22, 2024

Retrieved on:

금요일, 5월 17, 2024

Singular, ACU, Internet, Acme United Corporation

SHELTON, Conn., May 17, 2024 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) will present at the Singular Research Spring Select Webinar on Wednesday, May 22, 2024 at 4:30 pm ET/1:30 pm PT.

Key Points:

SHELTON, Conn., May 17, 2024 (GLOBE NEWSWIRE) -- Acme United Corporation (NYSE American: ACU) will present at the Singular Research Spring Select Webinar on Wednesday, May 22, 2024 at 4:30 pm ET/1:30 pm PT.
Investors interested in viewing presentations streamed live on the Internet, please use the following link to register for the Singular webinar: https://register.gotowebinar.com/register/7935223134977229402
A slide deck to be referenced by Acme United’s Chairman and CEO Walter C. Johnsen during the webinar will also be posted on the Investor Relations portion of the company’s website, www.acmeunited.com , prior to the company’s presentation.

LED Lighting and EV Charging Solutions Provider Orion Previews FY 2024 Results in Anticipation of its Singular Research Webinar Presentation Wed. May 22 at 3pm ET

Retrieved on:

목요일, 5월 16, 2024

Singular, EV, LED, Growth, FY, Q&A, Orion Energy Systems, Lighting, Orion, Pharmaceutical industry

CEO Mike Jenkins and CFO Per Brodin will provide an overview presentation for the Singular Research webinar, followed by an investor Q&A session.

Key Points:

CEO Mike Jenkins and CFO Per Brodin will provide an overview presentation for the Singular Research webinar, followed by an investor Q&A session.
Orion plans to report its fiscal 2024 results and hold a conference call on Thursday, June 6th at 10.00 a.m.
Orion reported preliminary Q4’24 revenue of approximately $26.4M, an increase of approximately 22% over Q4’23 revenue of $21.6M.
Orion also reported a preliminary FY 2024 revenue of approximately $90.6M, representing an approximate 17% increase over FY 2023 revenue of $77.4M.

Singular Genomics Reports Recent Highlights and First Quarter 2024 Financial Results

Retrieved on:

화요일, 5월 14, 2024

Singular, NGS, Investment, SAN, Genomics, OMIC, G4

SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the first quarter ended March 31, 2024.

Key Points:

SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the first quarter ended March 31, 2024.
Shipped six G4 systems in the first quarter of 2024, increasing the total number of commercial systems shipped to 30 as of the end of the first quarter of 2024.
Gross profit was negative $0.4 million in the first quarter of 2024, compared to $0.1 million in the first quarter of 2023.
Operating expenses for the first quarter of 2024 totaled $26.4 million, compared to $25.4 million for the first quarter of 2023.

Innovative Solutions & Support, Inc. to Participate in the Singular Research Spring Select Conference

Retrieved on:

금요일, 5월 17, 2024

Other Manufacturing, Other Transport, Technology, Air, Engineering, Transport, Other Technology, Aerospace, Manufacturing, Hardware, Singular, The Company, ISSC, Conference

Innovative Solutions & Support, Inc. (the "Company") (NASDAQ: ISSC) announced that Jeff DiGiovanni, Chief Financial Officer, will be participating in the Singular Research Spring Select Conference that will be held virtually May 22, 2024.

Key Points:

Innovative Solutions & Support, Inc. (the "Company") (NASDAQ: ISSC) announced that Jeff DiGiovanni, Chief Financial Officer, will be participating in the Singular Research Spring Select Conference that will be held virtually May 22, 2024.
The Company presentation will begin at 3:00PM PDT (6:00PM EDT) on May 22, 2024.
To register for access, please visit:

Labroots Announces the 12th Annual Precision Medicine: Genomics, Genetics & Molecular Diagnostics Virtual Event Series 2024

Retrieved on:

목요일, 5월 9, 2024

YORBA LINDA, Calif., May 9, 2024 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website and producer of educational virtual events and webinars, proudly announces the upcoming 12th Annual Precision Medicine Virtual Event Series. This premier virtual conference, scheduled for May 15, 2024, invites worldwide experts and enthusiasts to explore the latest innovations and advancements in precision medicine.

Key Points:

Join Labroots on May 15, 2024, for the 12th Annual Precision Medicine Virtual Event Series, exploring the latest in genomics, genetics, and molecular diagnostics, with keynote speakers, dynamic sessions, and opportunities for continuing education.
YORBA LINDA, Calif., May 9, 2024 /PRNewswire-PRWeb/ -- Labroots, the leading scientific social networking website and producer of educational virtual events and webinars, proudly announces the upcoming 12th Annual Precision Medicine Virtual Event Series .
This premier virtual conference, scheduled for May 15, 2024, invites worldwide experts and enthusiasts to explore the latest innovations and advancements in precision medicine.
This year's event will dive deep into the cutting-edge areas of genomics, genetics, and molecular diagnostics, pivotal in the ongoing revolution of personalized healthcare.

Opn Announces Appointment of Vaden C. Landers as President and CEO of MerchantE

Retrieved on:

수요일, 4월 17, 2024

Professional Services, Payments, Data Management, Technology, Software, Finance, Fintech, Singular, Sale, ISO, Risk management, Multimedia, Marketing, Global Payments, Organization, Growth

OPN Holdings (operating as “Opn”), the one-stop financial solutions company from Southeast Asia, today announced that payments industry veteran Vaden C. Landers has been named President and Chief Executive Officer of MerchantE, its U.S. subsidiary.

Key Points:

OPN Holdings (operating as “Opn”), the one-stop financial solutions company from Southeast Asia, today announced that payments industry veteran Vaden C. Landers has been named President and Chief Executive Officer of MerchantE, its U.S. subsidiary.
View the full release here: https://www.businesswire.com/news/home/20240417860295/en/
In his role, Landers will be responsible for overseeing and accelerating growth at Alpharetta, Georgia-based MerchantE, including bolstering the financial solutions and integrations that it provides to businesses and speeding its expansion into new geographic markets and verticals.
Landers was also notably a member of the original management team that took Global Payments public in 2001 while serving as its President of the ISO Business.
“Vaden is an exceptional leader whose proven track record of driving sustained results and growing real value is what MerchantE needs,” said Ezra Don Harinsut, Opn’s Co-founder and Group CEO.

PROSE, GLOBAL LEADER IN PERSONALIZATION, UNVEILS ITS AI-POWERED BEAUTYTECH PLATFORM

Retrieved on:

수요일, 4월 10, 2024

Singular, AI, Software, API, Environment, Beauty, CO, Sales

NEW YORK, April 10, 2024 /PRNewswire/ -- Today, Prose, the global leader in personalization, unveils Singular™, its end-to-end AI platform that allows the brand to offer custom beauty at scale through both innovative software and hardware technologies.

Key Points:

It's a clear demonstration of how AI can enhance personalization in beauty and drive further satisfaction for consumers.
Prose utilizes the AI-powered BeautyTech platform's four integrated components:
Singular ID analyzes and collects a consumer's beauty needs and goals, starting with designing a comprehensive view of the individual's beauty profile.
Singular Commerce powers front- and back-end commerce operations with an API-based architecture—transforming prospects into loyal customers through a seamless, integrated experience.
"This platform, which Prose has been using since 2017, underscores our belief in the power of AI, software, and hardware technologies to drive the beauty industry forward.

Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2023 Financial Results

Retrieved on:

월요일, 3월 18, 2024

Singular, Growth, SAN, Tissue, NGS, RNA, Proteomics, Workflow, Investment, Genomics, OMIC, Network throughput, H&E, Video game

“We ended 2023 on a strong note, shipping our largest number of quarterly instruments to-date,” said Drew Spaventa, Chairman and Chief Executive Officer of Singular Genomics.

Key Points:

“We ended 2023 on a strong note, shipping our largest number of quarterly instruments to-date,” said Drew Spaventa, Chairman and Chief Executive Officer of Singular Genomics.
Shipped eight G4 systems in the fourth quarter of 2023, increasing the total number of commercial systems shipped to 24 as of the end of the fourth quarter of 2023.
Operating expenses for the fourth quarter of 2023 totaled $24.8 million, compared to $22.5 million for the fourth quarter of 2022.
Operating expenses included non-cash stock-based compensation of $2.7 million for the fourth quarter of 2023 and $3.1 million for the fourth quarter of 2022.